Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study

Insulin-Like Growth Factor Bioactivity, Stanniocalcin-2, Pregnancy-Associated Plasma Protein-A, and IGF-Binding Protein-4 in Pleural Fluid and Serum From Patients With Pulmonary Disease

(2017) Ulrick Skipper Espelund et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Physiology and pathophysiology of IGFBP-1 and IGFBP-2 – Consensus and dissent on metabolic control and malignant potential

(2015) Andreas Hoeflich et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment

(2015) Ulrick Espelund et al.   GROWTH HORMONE & IGF RESEARCH

IGFBP-2/PTEN: A critical interaction for tumours and for general physiology?

(2015) Li Zeng et al.   GROWTH HORMONE & IGF RESEARCH

Changes in Insulin-Like Growth Factor-I and Its Binding Proteins Are Associated with Diabetes Mellitus in Older Adults

(2015) Chino S. Aneke-Nash et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma

(2015) Jacob Thomsen et al.   Oncotarget

The role of PAPP-A in the IGF system: location, location, location

(2015) Claus Oxvig   Journal of Cell Communication and Signaling

Pregnancy-associated plasma protein-A expression in human breast cancer

(2014) Aaron S. Mansfield et al.   GROWTH HORMONE & IGF RESEARCH

Twelve Serum Proteins Progressively Increase With Disease Stage in Squamous Cell Cervical Cancer Patients

(2014) Wenbo Zhi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis

(2014) Malene R. Jepsen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Age- and Sex-Specific Reference Intervals Across Life Span for Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 Ratio Measured by New Automated Chemiluminescence Assays

(2014) Nele Friedrich et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach

(2014) Le Kang et al.   STATISTICS IN MEDICINE

Circulating IGF system and treatment outcome in epithelial ovarian cancer

(2013) Yu-Fang Huang et al.   ENDOCRINE-RELATED CANCER

Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer

(2013) Zachary W. Kendrick et al.   HPB

Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer

(2012) Catherine Duggan et al.   INTERNATIONAL JOURNAL OF CANCER

Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data

(2011) R. M. Simon et al.   BRIEFINGS IN BIOINFORMATICS

Overexpression of Pregnancy-Associated Plasma Protein-A in Ovarian Cancer Cells Promotes Tumor Growthin Vivo

(2011) Henning B. Boldt et al.   ENDOCRINOLOGY

Improved performance on high-dimensional survival data by application of Survival-SVM

(2010) V. Van Belle et al.   BIOINFORMATICS

The development of composite circulating biomarker models for use in anticancer drug clinical development

(2010) Lee J. Lancashire et al.   INTERNATIONAL JOURNAL OF CANCER

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk

(2010) Peter E. Clayton et al.   Nature Reviews Endocrinology

An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies

(2009) L. J. Lancashire et al.   BRIEFINGS IN BIOINFORMATICS

The current status of IGF-I assays – A 2009 update

(2009) Jan Frystyk et al.   GROWTH HORMONE & IGF RESEARCH

Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications

(2008) Maj-Lis M. Talman et al.   ACTA ONCOLOGICA

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

(2008) Susanne Møller et al.   ACTA ONCOLOGICA

Serum Insulin-Like Growth Factor-I and Platelet-Derived Growth Factor as Biomarkers of Breast Cancer Prognosis

(2008) P. Pasanisi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tumor dormancy: Elevated expression of stanniocalcins in late relapsing breast cancer

(2008) Kristiina Joensuu et al.   CANCER LETTERS

Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741

(2008) C. S. Fuchs et al.   CLINICAL CANCER RESEARCH

Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer

(2008) A. I. So et al.   CLINICAL CANCER RESEARCH

Elevated free IGF2 levels in localized, early-stage breast cancer in women

(2008) Ulrick Espelund et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY